Cat.#: BBM-C-129
Description | Rat Primary Brain Microvascular Endothelial Cells (RPBECs) from Ace Therapeutics are isolated from the brain tissue of 1-day-old neonatal Sprague-Dawley rats. Each vial contains at least 1×10^6 cells per ml and is delivered frozen. |
Species | Rat |
Source | Brain |
Recommended Medium | It is recommended to use Rat Brain Microvascular Endothelial Cells Medium Kit |
Cell Type | Endothelial |
Disease | Normal |
Quality Control | Rat Primary Brain Microvascular Endothelial Cells (RPBECs) test negative for bacteria, yeast, fungi, and mycoplasma. |
Shipping and Storage | Ace Therapeutics ships frozen cells using dry ice. Upon receiving the frozen cells, immediately move them into liquid nitrogen (-180 °C) for storage. Note: Never can cells be kept at -20 °C, and repeated freezing and thawing of cells is not recommended. |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Description | Price |
---|---|---|---|
BBM-C-142 | Mouse Astrocytes-brain stem from CD1 |
Mouse Astrocytes-brain stem from CD1 (MA-bs) are isolated from embryonic day 15 mouse brain stem. MA-bs are cryopreserved as primary cultures and delivered frozen.
|
inquiry |
BBM-C-125 | CD1 Mouse Brain Microvascular Endothelial Cells |
CD1 Mouse Brain Microvascular Endothelial Cells from Ace Therapeutics are isolated from brain tissue of pathogen-free laboratory mice. Each vial contains at least 1×10^6 cells per ml and is delivered frozen.
|
inquiry |
BBM-C-141 | Mouse Astrocytes-midbrain from CD1 |
Mouse Astrocytes-midbrain from CD1 (MA-mb) are isolated from embryonic day 15 mouse midbrain. MA-mb are cryopreserved as primary cultures and delivered frozen.
|
inquiry |
BBM-C-128 | BALB/c Mouse Brain Microvascular Endothelial Cells |
BALB/c Mouse Brain Microvascular Endothelial Cells from Ace Therapeutics are isolated from the brain tissue of pathogen-free laboratory mice. Each vial contains at least 1×10^6 cells per ml and is delivered frozen.
|
inquiry |
BBM-C-124 | Human Astrocytes |
Human Astrocytes from Ace Therapeutics are isolated from the human cerebral cortex, cryopreserved at passage one. Each vial contains at least 5×10^5 cells per ml and is delivered frozen.
|
inquiry |
BBM-C-123 | Human Brain Microvascular Pericytes |
Human brain microvascular pericytes (HBMVPCs) perform numerous tasks which include playing a vital part in constructing and maintaining the blood-brain barrier, controlling angiogenesis, ensuring endothelial cell survival, and engulfing cellular waste.
Human Brain Microvascular Pericytes from Ace Therapeutics are isolated from normal human brain cortical tissue. Each vial contains at least 5×10^5 cells per ml and is delivered frozen.
|
inquiry |
BBM-C-150 | Rabbit Astrocytes |
Rabbit Astrocytes from Ace Therapeutics are isolated from rabbit brains and are cryopreserved at passage one. Rabbit Astrocytes are characterized by immunofluorescence with antibody specific to GFAP. Each vial contains at least 0.5×10^6 cells per ml and is delivered frozen.
|
inquiry |
BBM-C-145 | Wistar Rat Astrocytes |
Characterization: 1. Cell Activity;
– Recovery Viability ≥ 80%.
2. Cell Purity;
– GFAP-positive cells ≥ 70%.
– β-tubulin III- or doublecortin- (Dcx-) positive cells ≤ 10%.
– GalC-positive cells ≤ 10%.
|
inquiry |
BBM-C-139 | CD1 Mouse Astrocytes |
CD1 Mouse Astrocytes from Ace Therapeutics are isolated from postnatal day 2 mouse brains. MA is characterized by immunofluorescence with antibodies specific to GFAP. Each vial contains at least 1×10^6 cells per ml and is delivered frozen.
|
inquiry |
BBM-C-134 | Rabbit Brain Microvascular Endothelial Cells |
Rabbit Brain Microvascular Endothelial Cells from Ace Therapeutics are isolated from the brain tissue of a pathogen-free New Zealand White Rabbit. Each vial contains at least 1×10^6 cells per ml and is delivered frozen.
|
inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.